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http://dx.doi.org/10.1016/j.pedneo.2Background: Intrauterine infection is the most commonly identified cause of preterm birth. In
this study, our aim was to determine the association between placental inflammation and
neonatal outcome in a prospective observational cohort of preterm infants of less than 34
weeks gestational age. We especially focused on the distinct effects of maternal inflammatory
response (MIR) with and without fetal inflammatory response (FIR).
Methods: Clinical characteristics and placental histological results were prospectively
collected from 216 singleton infants born at a gestational age of less than 34 weeks.
Results: Of the 216 newborns, 104 (48.1%) infants had histological placental inflammation.
Based on their pathological findings, the premature infants were divided into three groups:
(1) the MIR negativeFIR negative (MIRFIR) group; (2) the MIR positiveFIR positive
(MIRþFIRþ) group; and (3) the MIR positiveeFIR negative (MIRþFIR) group. The incidence
of neonatal respiratory distress syndrome (RDS) in the MIRþFIR group (5.7%) and in the
MIRþFIRþ group (2.0%) was significantly lower than in the MIRFIR group (19.6%)
(p < 0.05). Logistic regression analysis showed that MIRþFIRþ group had a decreased inci-
dence of neonatal RDS (ORZ 0.076; 95% CI 0.009e0.624; pZ 0.016). The incidence of intra-
ventricular hemorrhage (IVH) Grade 2 or greater was significantly higher in the MIRþFIRþ
group (42.3%) than in the MIRþFIR group (13.0%) (p < 0.05) or in the MIRFIR group
(15.2%) (p < 0.05). Logistic regression analysis also showed that MIRþFIRþ was associated
with an increased incidence of IVH Grade 2 or greater (OR Z 4.08; 95% CI 1.259e13.24;
p Z 0.019).ospital of Fudan University, 399 Wanyuan Road, Shanghai 201102, China.
cn (Y. Yang).
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36 Z. Liu et alConclusion: A positive MIR in association with a positive FIR decreases the risk of RDS, but in-
creases the risk of IVH Grade 2 or greater in preterm infants with a gestational age of less
than 34 weeks. However, a positive MIR alone has little effect on neonatal outcome.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Preterm birth remains an important cause of neonatal
mortality and longterm morbidity, despite enormous ad-
vances in neonatal intensive care.1 Intrauterine infection is
the most common identified cause of preterm birth; cho-
rioamnionitis is present in approximately 40e70% of women
who deliver prematurely.2 Chorioamnionitis is primarily the
result of ascending bacteria from the vagina and cervix.
Most identified pathogens in the uterus that are associated
with preterm labor are of vaginal origin. Examples of such
pathogens are Ureaplasma urealyticum, Chlamydia tra-
chomatis, Neisseria gonorrhoea, Mycoplasma hominis,
Group B Streptococcus, and Trichomonas vaginalis.3 An
uncommon pathway of intrauterine infection is by blood-
borne spread. Pathogenic colonization of the intrauterine
space leads to placental inflammatory response, which is
associated with preterm labor.
Two well-characterized types of placental inflammation
are: (1) the maternal inflammatory response (MIR), which
includes subchorionitis, chorionitis or chorioamnionitis; and
(2) the fetal inflammatory response (FIR), which includes
chorionic vasculitis, umbilical phlebitis or vasculitis, (sub-
acute) necrotizing funisitis, or concentric umbilical peri-
vasculitis.4,5 Some studies indicate that MIR and/or FIR are
associated with preterm birth and neonatal prematurity
complications such as respiratory distress syndrome (RDS),
chronic lung disease, necrotizing enterocolitis (NEC), and
intraventricular hemorrhage (IVH).6,7 However, there are
few reports in China on the effects of placental inflamma-
tion (identified by histopathological examination) on
neonatal outcome.
In this study, our aim was to determine the association
between placental inflammation and neonatal outcome in a
prospective observational cohort of preterm infants with a
gestational age of less than 34 weeks. We especially
focused on the distinct effects of MIR with and without FIR.2. Methods
The effects of placental inflammation on neonatal outcome
in preterm infants were explored in pregnant women who
delivered preterm infants between January 2008 and
October 2010 at the International Peace Maternity and
Child Health Hospital of China Welfare Institution
(Shanghai, China). Eligibility requirements were that an
infant had to be a singleton, alive, and born before 34
weeks of gestation. Women with multiple-gestation preg-
nancies and newborns with major birth defects were
excluded. The medical ethics committee of the hospital
approved the study and all patients provided written
consent.2.1. Clinical characteristics of the study population
The prenatal, perinatal, and neonatal data were collected
and stored in a database. Neonates who were transferred to
another hospital were followed to complete the data re-
cord. The demographic and clinical variables examined
included gestational age, birth weight, intrapartum man-
agement, and pregnancy complications.
We used the following clinical definitions in this study:
1. Gestational age at delivery was determined on the
basis of the last menstrual period and early ultrasound
findings (i.e., before 20 weeks of gestation).
2. Gestational hypertension was defined as new onset
hypertension (i.e., blood pressure greater than 140/
90 mmHg).
3. Fetal distress was diagnosed by the obstetrician and
was based on cardiotocographic criteria.
4. A full course of prenatal steroid treatment was defined
as 6 mg of dexamethasone delivered intramuscularly
every 12 hours for a total of four times.
5. Respiratory distress syndrome (RDS) was defined as the
presence of respiratory symptoms such as grunting and
chest retraction, typical chest radiograph findings,
and/or treatment with surfactant and the need for
assisted ventilation (including nasal continuous positive
airway pressure and mechanical ventilation).
6. Bronchopulmonary dysplasia (BPD) was defined as
supplemental oxygen dependency at 36 weeks of cor-
rected gestational age.
7. Patent ductus arteriosus (PDA) was suspected on the
basis of clinical symptoms (e.g., systolic murmur,
widened pulse pressure, hyperdynamic precordium)
and confirmed by echocardiogram.
8. Necrotizing enterocolitis (NEC) was defined as stage II
or above (using Bell’s classification).
9. Retinopathy of prematurity (ROP) was defined accord-
ing to the International Classification for Retinopathy
of Prematurity.
10. A diagnosis of sepsis was based on the 2003 Kunming
Neonatal Sepsis Definitions Conference criteria.8
According to this conference, the diagnostic criteria
for confirmed sepsis are a positive clinical/laboratory
screen and a positive culture. Clinical sepsis was defined
as a positive clinical/laboratory screen and negative
cultures. Early-onset neonatal sepsis was recorded if it
occurred during the first 72 hours after birth.
11. Intraventricular hemorrhage (IVH) and periventricular
leukomalacia (PVL) were defined by serial head ultra-
sound,performedaccording to thedescriptionbyVolpe.9
The first head ultrasound was performed within 3 days
after birth and follow-up head ultrasound examinations
were performed every week until the day of discharge.
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Placentae and membranes were fixed in formalin immedi-
ately after delivery. Sampling included two membrane rolls,
two cross-sections of the cord, and three blocks of the
placental disk. The tissues were embedded in paraffin until
histopathological examination. All placentae were examined
for histologic evidence of inflammation by an experienced
pathologist who was blinded to the clinical information. The
placental inflammation was classified as maternal inflamma-
tory response (MIR) and fetal inflammatory response (FIR) in
accordancewith thedefinitionby theAmniotic Fluid Infection
Nosology Committee.5 The MIR includes subchorionitis, cho-
rionitis, or chorioamnionitis. The FIR includes chorionic
vasculitis, umbilical phlebitis or vasculitis, (subacute)
necrotizing funisitis, or concentric umbilical perivasculitis.
2.3. Statistical analysis
Continuous data are presented as the mean  standard
deviation (SD). Dichotomous data are expressed by the
frequency and associated percentage. Differences between
groups were tested by analysis of variance (ANOVA) for
continuous data or by the c2 test for dichotomous data.
Logistic regression analysis was performed to identify risk
factors for RDS and for IVH Grade 2 or greater. Significance
was accepted at p < 0.05 (two-sided). All analyses were
performed by using SPSS version 11.5 software (SPSS Inc,
Chicago, IL).
3. Results
3.1. Placental pathology and perinatal
characteristics
During the study period, 216 preterm (i.e., before 34 weeks
of gestation), singleton live-born neonates were enrolled.Table 1 Perinatal clinical characteristics of the three groups.
Characteristics MIRFIR (n Z 112)
Maternal age (y) 29.96  4.54
Gestational age (d) 223.33  11.60
Cesarean section 82 (73.2)
Labor 35 (31.3)
Male 65 (58.0)
Placental weight (g) 367.79  90.01
Birth weight (g) 1692.12  443.37
Fetal distress 34 (30.4)
PPROM 30 (26.8)
Gestational hypertension 50 (44.6)
Prenatal antibacterial 43 (38.4)
Prenatal steroids
None 11 (9.8)
Non-full course 59 (52.7)
Full course 42 (37.5)
FIR Z fetal inflammatory response; MIR Z maternal inflammatory re
Data are expressed as n (%) or mean  standard deviation.
* Compared to the MIRFIR group, p < 0.05.Placental pathology showed that MIR was present in 104
(48.1%) mothers and that 51 (49.0%) infants of these
mothers had signs of FIR. There were no cases of FIR
without MIR. Based on the placental pathology, the study
population was divided into 3 groups: (1) the MIR neg-
ativeFIR negative (MIRFIR) group; (2) the MIR pos-
itiveFIR positive (MIRþFIRþ) group; and (3) the MIR
positiveFIR negative (MIRþFIR) group. Table 1 shows the
perinatal clinical characteristics of the three groups. Be-
tween the three groups, there were no significant differ-
ences in gestational age; birth weight; sex; intrauterine
distress; Apgar score at 1 minute of 7 or less; Apgar score at
5 minutes of 7 or less; or prenatal steroids use. The
MIRþFIR and MIRþFIRþ groups had significantly higher
rates of preterm premature rupture of membranes, labor,
and prenatal antibacterial therapy, compared to the
MIRFIR group. Mothers in the MIRFIR group were
conversely more likely to have gestational hypertension and
deliver by cesarean section.
3.2. Placental inflammation and neonatal outcome
Table 2 shows the neonatal outcome parameters of the
three groups. The incidence of transient tachypnea in the
groups was not significantly different. However, the inci-
dence of RDS, the use of nasal continuous positive airway
pressure, and the use of mechanical ventilation was
significantly lower in infants in the MIRþFIR group or
MIRþFIRþ group than in infants in the MIRFIR group.
Placental inflammation (MIR or FIR) seemed to increase the
risk of early-onset sepsis, but the change was not statisti-
cally significant.
Ninety-five infants completed serial head ultrasound
examination, and 41 of the infants had brain injuries.
Intraventricular hemorrhage occurred more often in the
MIRþFIRþ group (57.7%) than in the MIRþFIR group (34.8%)
or the MIRFIR group (39.1%), but this difference was not
statistically significant. Intraventricular hemorrhage GradeMIRþFIR (n Z 53) MIRþFIRþ (n Z 51)
29.91  4.10 29.18  5.05
220.83  11.97 219.57  10.97
15 (28.3)* 18 (35.3)*
44 (83.0)* 36 (70.6)*
35 (66.0) 25 (49.0)
401.44  81.43* 400.04  83.98
1747.11  371.52 1688.90  392.00
5 (9.4) 12 (23.5)
31 (58.5)* 44 (86.3)*
0 (0)* 2 (3.9)*
39 (73.6)* 45 (88.2)*
7 (13.2) 5 (9.8)
19 (35.8) 27 (52.9)
27 (50.9) 19 (37.3)
sponse; PPROM Z preterm premature rupture of membranes.
Table 2 Neonatal outcome.
Outcome parameter N (%) MIRFIR (n Z 112) MIRþFIR (n Z 53) MIRþFIRþ (n Z 51)
RDS 22 (19.6) 3 (5.7)* 1 (2.0)*
Transient tachypnea 16 (14.3) 5 (9.4) 11 (21.6)
Surfactant administered 66 (58.9) 23 (43.4) 23 (45.1)
Mechanical ventilation 45 (40.2) 11 (20.8)* 10 (19.6)*
BPD 7 (6.3) 7 (13.2) 3 (5.9)
Apgar score 7 at 1 min 28 (25.0) 7 (13.2) 8 (15.7)
Apgar score 7 at 5 min 8 (7.1) 2 (3.8) 3 (5.9)
PDA 8 (7.1) 3 (5.7) 3 (5.9)
NEC 4 (3.6) 1 (1.9) 2 (3.9)
ROP 0 (0) 0 (0) 0 (0)
Sepsis
Early onset 8 (7.1) 6 (11.3) 8 (15.7)
Culture proven 0 (0) 2 (3.8) 2 (3.9)
Clinical sepsis 8 (7.1) 4 (7.5) 6 (11.8)
Late onset 26 (23.2) 12 (22.6) 18 (35.3)
Culture proven 12 (10.7) 4 (7.5) 9 (17.6)
Clinical sepsis 14 (12.5) 8 (15.1) 9 (17.6)
Death 6 (5.4) 3 (5.7) 1 (2.0)
BPD Z bronchopulmonary dysplasia; FIR Z fetal inflammatory response; MIR Z maternal inflammatory response; NEC Z necrotizing
enterocolitis; PDA Z patent ductus arteriosus; RDS Z respiratory distress syndrome.
Data are expressed as n (%).
* Compared to the MIRFIR group, p < 0.05.
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MIRþFIRþ group than in the other two groups. The rate of
cystic periventricular leukomalacia was not significantly
different between the groups (Table 3).
In the multivariable model, the MIRþFIRþ group had a
significantly reduced risk for RDS (odds ratio [OR] Z 0.076;
95% CI 0.009e0.624; p Z 0.016), when adjusted for
gestational age, gestational hypertension, and labor. The
MIRþFIR group also seemed to have decreased odds for
RDS, after controlling for potential confounders, but the
difference was not statistically significant (OR Z 0.279,
95% CI 0.069e1.125, p Z 0.073). When adjusted for
gestational age, birth weight and early onset sepsis, the
MIRþFIRþ group had an increased risk of IVH Grade 2 or
greater (OR Z 4.08; 95% CI 1.259e13.24; p Z 0.019). The
MIRþFIR group did not have an increased risk of IVH
Grade 2 or greater (OR Z 0.85; 95% CI 0.193e3.74;
p Z 0.83).Table 3 Neonatal brain injury in three groups.
MIRFIR (n Z 46)
IVH (all grades) 18 (39.1)
IVH (Grade IIeIV) 7 (15.2)
IVH (Grade IIIeIV) 3 (6.5)
Cystic PVL 2 (4.3)
FIRZ fetal inflammatory response; IVHZ Intraventricular hemorrhag
leukomalacia.
Data are expressed as n (%).
* Compared to the other two groups, p < 0.05.4. Discussion4.1. Placental inflammation in preterm birth
This study showed that 48.1% of preterm infants were
exposed to prenatal intrauterine inflammation, which is in
line with the results of other reports.10,11 There was
interestingly no infant with only FIR in the study popula-
tion, although FIR without MIR is believed to occur rarely
and via the blood stream.2 Intrauterine inflammation,
which includes maternal and fetal responses to infection, is
associated with preterm delivery.12 Our findings of
increased preterm premature rupture of membranes asso-
ciated with maternal and fetal inflammation are in agree-
ment with these previous reports.11,13 Fetal inflammation
in the placenta is regarded as the more serious type of in-
trauterine inflammation.MIRþFIR (n Z 23) MIRþFIRþ (n Z 26)
8 (34.8) 15 (57.7)
3 (13.0) 11 (42.3)*
1 (4.3) 4 (15.4)
0 (0) 0 (00)
e; MIRZ maternal inflammatory response; PVLZ periventricular
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distress syndrome
In this study, univariate analyses showed that placental
inflammation was associated with a decreased incidence of
RDS, whether MIR was associated with or without FIR.
However, after multivariable adjustment, only MIR with FIR
showed a reduced incidence of RDS.
Watterberg et al14 reported that exposure to placental
inflammation decreased the risk of RDS. Since their report,
many researchers have explored the relationship between
placental inflammation and RDS, but the results of these
studies have been inconsistent.15,16 Kaukola et al17
demonstrated in a prospective cohort that histological
chorioamnionitis was associated with a lower risk of RDS;
however several studies have reported no relationship be-
tween placental inflammation and RDS.8,19 Furthermore,
these studies did not subdivide the study population
according to the presence or absence of FIR.17e19
A large cohort study of 724 preterm infants of less than
30 weeks gestational age showed that the presence of
chorioamnionitis with umbilical vasculitis was associated
with a markedly greater reduction of RDS than was cho-
rioamnionitis alone.10 Our data suggest that the additional
presence of FIR in the placenta can provide the protective
effect against neonatal RDS in preterm infants that are less
than 34 weeks gestational age, but MIR alone has little ef-
fect on RDS.
Animal experiments have demonstrated that prenatal
inflammation exposure can induce maturation of fetal
lungs.20 For instance, intra-amniotic injection of endotoxin
can produce intrauterine inflammation and elicit the pro-
duction of surfactant proteins in the fetal lung.21 Intra-
amniotic interleukin-1 (IL-1)22 and ureaplasma23 also
induce lung maturation in fetal sheep.4.3. Placental inflammation and brain injury
Common neonatal brain injuries of preterm infants are
IVH and white matter disease (WMD), which comprises
cystic and noncystic periventricular leukomalacia (PVL).
Magnetic resonance imaging recently indicates that non-
cystic PVL accounts for most cases of WMD.24 The inci-
dence of cystic PVL has progressively decreased. Several
studies show that chorioamnionitis with or without fetal
involvement was associated with neonatal brain injury,
including WMD and IVH.25,26 A meta-analysis of observa-
tional studies by Wu et al27 also reports that clinical
chorioamnionitis was associated with cystic PVL and ce-
rebral palsy.
In the present study, univariate analyses showed MIR
with FIR was associated with an increased incidence of IVH
Grade 2 or greater. The effect furthermore remained after
adjusting for gestational age, birth weight, and early onset
sepsis. In this population of preterm infants, 1% (2/216) of
the neonates experienced cystic PVL. We found no influ-
ence of placental inflammation on WMD, as other studies
have reported. This inconsistency may be attributable to
the lower sensitivity of cranial ultrasound in detecting
noncystic PVL and the relatively older age of our study
population.Intrauterine inflammation can potentially lead to FIR
and increase the local production of cytokines in the fetal
brain, thereby damaging the bloodebrain barrier.28 An
animal study showed that intrauterine Lipopolysaccharide
induced the immune response in the placenta and in the
fetal brain, which significantly decreased dendritic counts
in cortical cultures.29
4.4. Placental inflammation and sepsis or other
neonatal diseases
Sepsis greatly contributes to the mortality and morbidity of
preterm infants. Early onset sepsis is typically associated
with vertical transmission of infection from the mother to
her infant and is often caused by organisms that colonize
the maternal genitourinary tract. A cohort study of 3094
infants showed that clinical chorioamnionitis was associ-
ated with a 5.5-fold increase in the incidence of early onset
sepsis.30 Several studies also indicate that histologic cho-
rioamnionitis seemed to increase the risk of early onset
sepsis in preterm infants.26,31,32 In the present study, the
trend of increasing neonatal early onset sepsis was present
in the intrauterine inflammation-exposed newborns,
although the difference was not statistically significant.
Bronchopulmonary dysplasia (BPD) is one of the most
frequent sequelae in very preterm infants. A systematic
review and meta-analysis suggest that chorioamnionitis was
significantly associated with BPD.33 However, there was no
association between placental inflammation and the inci-
dence of BPD in the present cohort study. A possible
explanation for the discrepancy is that the patient popu-
lation of our study was relatively older.
5. Conclusion
A positive MIR with a positive FIR decreases the risk of RDS
but increases the risk of IVH Grade 2 or greater in preterm
infants with a gestational age of less than 34 weeks. How-
ever, a positive MIR alone has little effect on neonatal
outcome.
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